http://www.mail.com/companies/58222-bristol-myers-squibb-company.html Mail.com - the best personalized free web-based Email en en http://sec-s.uicdn.com/mail.com/2.28/img/mailcom_logo_rss.png http://www.mail.com/companies/58222-bristol-myers-squibb-company.html http://www.mail.com/business/economy/2057866-sanofi-earnings-slashed-quarter.html PARIS (AP) — French drug maker Sanofi said Thursday its net profit was slashed in the first quarter from a year earlier as falling sales and patent losses on key drugs combined to hammer earnings. Sanofi's net profit was €1 billion ($1.3 billion) in the January-March quarter, down 45 percent from €1.8 billion a year earlier. Revenue from Plavix, which had... Thu, 02 May 2013 06:55:07 GMT http://www.mail.com/business/economy/2057866-sanofi-earnings-slashed-quarter.html 2013-05-02T06:55:07Z http://www.mail.com/scitech/health/1991800-indias-rejection-drug-patent-reverberate.html The India Supreme Court's rejection of a patent for an improved version of a costly cancer drug by Novartis AG could have big implications for the world's largest drugmakers. The ruling, which was handed down on Monday, signals the latest shift in the world of drug development in emerging markets such as India and Brazil, where drugmakers have been lookin... Tue, 02 Apr 2013 01:06:08 GMT http://www.mail.com/scitech/health/1991800-indias-rejection-drug-patent-reverberate.html 2013-04-02T01:06:08Z http://www.mail.com/scitech/health/1987128-fda-oks-first-of-its-kind-diabetes-drug-jj.html WASHINGTON (AP) — The Food and Drug Administration on Friday approved a first-of-its-kind diabetes drug from Johnson & Johnson that uses a new method to lower blood sugar — flushing it out in patients' urine. The agency cleared J&J's Invokana tablets for adults with Type 2 diabetes, which affects an estimated 26 million Americans. The once-a-day medicatio... Fri, 29 Mar 2013 19:39:49 GMT http://www.mail.com/scitech/health/1987128-fda-oks-first-of-its-kind-diabetes-drug-jj.html 2013-03-29T19:39:49Z http://www.mail.com/scitech/health/1954684-fda-probes-pancreas-risks-with-diabetes-drugs.html WASHINGTON (AP) — The Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems. The agency said Thursday samples of pancreas tissue taken from a small number of patients showed inflammation and cellular changes that often precede cancer. Aca... Thu, 14 Mar 2013 20:21:27 GMT http://www.mail.com/scitech/health/1954684-fda-probes-pancreas-risks-with-diabetes-drugs.html 2013-03-14T20:21:27Z http://www.mail.com/scitech/health/1853298-pfizer-q4-net-jumps-sale-nutrition-business.html Drugmaker Pfizer Inc.'s fourth-quarter results easily beat Wall Street expectations, driving up its stock, as profit more than quadrupled, due to tighter spending and a $4.8 billion gain from selling its nutrition business. Those boosts offset competition from generic drugs hurting sales of Lipitor and other medicines. The world's biggest drugmaker said T... Tue, 29 Jan 2013 22:04:00 GMT http://www.mail.com/scitech/health/1853298-pfizer-q4-net-jumps-sale-nutrition-business.html 2013-01-29T22:04:00Z